✦ LIBER ✦

Low-dose oral chloroquine in the treatment of porphyria cutanea tarda

✍ Scribed by R.E. ASHTON; J.L.M. HAWK; I.A. MAGNUS

Book ID: 108658749
Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 310 KB
Volume: 111
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1984.tb06632.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Photosensitivity after treatment of porp

Photosensitivity after treatment of porphyria cutanea tarda with low dose chloroquine

✍ P. GOULD 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 715 KB

Chloroquine in the treatment of porphyri

Chloroquine in the treatment of porphyria cutanea tarda

✍ Edemariam Tsega; Abraham Besrat; Belai Damtew; Elias Seyoum; J.W. Landells 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 393 KB

D-Penicilamine in the Treatment of Porph

D-Penicilamine in the Treatment of Porphyria Cutanea Tarda

✍ G. A. Hunter; G. F. Donald 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Patterns of porphyrin excretion in porph

Patterns of porphyrin excretion in porphyria cutanea tarda under venesection treatment

✍ R.Enríquez De Salamanca; R. Rico; M.L. Pena; F. Romero; A. Olmos; J. Jimenez 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 465 KB

Actinic reticuloid developing in the cou

Actinic reticuloid developing in the course of porphyria cutanea tarda

✍ L. Schnitzler; B. Schubert; P. Belperron; J.L. Verret 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Low prevalence of hepatitis C virus infe

Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in germany

✍ Ulrich Stölzel; Erich Köstler; Christiane Koszka; Maricka Stöffler-Meilicke; Det 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 1 views

Previous studies from Spain, Italy, and France have demonstrated a high prevalence (71% to 91%) of antibodies against hepatitis C virus in patients with porphyria cutanea tarda (PCT). To determine the role of hepatitis C virus (HCV) in PCT in Germany, we have assessed the prevalence of antibodies ag